Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. Transcript, audio, 6-K call announcement stay in one workspace.
Earnings call · FY2026 Q1
Executive readout · one minute
Read the call alongside every captured source. Transcript, audio, 6-K call announcement stay in one workspace.
Management tone
Confident
Net tone +72 · low hedging
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
Stated verbally and extracted from the transcript.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Gross margin
Q3 and beyond
|
20% – 25% | — | |
|
Gross margins
going forward, Q3 and beyond
|
20% – 25% | — | |
|
U.K. market growth
this year
|
60% – 100% | — | |
|
White label share of sales
next five years
|
20% | — |
Good morning. My name is Ina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Hightide First Fiscal Quarter 2026 Unaudited Financial and Operational Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star, then the number 1 on your telephone keypad. If you would like to withdraw your question, please press star, then the number two. Thank you. Mr. Brownlee, you may begin your conference.
Thank you, Operator. Good morning, everyone, and welcome to High Tidings Quarterly Earnings Call. Joining me on the call today are Mr. Raj Grover, President and Chief Executive Officer, and Mr. Mayank Mahajan, Chief Financial Officer. On March 17, 2026, the company released financial and operational results for the fiscal quarter that ended January 31, 2026. Before we begin, please let me remind you that during the course of this conference call, high-tides management may make statements, including with respect to management's expectations or estimates of future performance. All such statements, other than statements of historical facts, constitute forward-looking information or forward-looking statements within the meaning of the applicable securities laws and are based on assumptions, expectations, estimates, and projections as of the date hereof. Specific forward-looking statements include, without limitation, all disclosures regarding future results of operations, economic conditions, and anticipated courses of action. For more information on the company's risks and uncertainties related to forward-looking statements, please refer to the company's press release dated March 17, 2026, our latest annual information form, and our latest management discussion and analysis, each filed with securities regulatory authorities at cedarplus.ca or on EDGAR at www.sac.gov forward slash EDGAR or on the company's website at www.hightideinc.com and which are hereby incorporated by reference herein. Although these forward-looking statements reflect management's current beliefs and reasonable assumptions based on the currently available information to management as of the date hereof, we cannot be certain that the actual results will be consistent with the forward-looking statements in the future. There can be no assurance that actual outcomes will not differ materially from these results. Accordingly, we caution you not to place undue reliance upon such forward-looking results. For any reconciliation of non-IFRS measures, measures been discussed, please consult our latest management discussion and analysis filed on CEDAR Plus and EDGAR. It is now my pleasure to introduce Mr. Raj Grover, President and Chief Executive Officer of Hightide. Thank you, Mr. Grover. You may begin.
Thank you, Carter, and good morning, everyone. Welcome to High Tidings Financial Results Conference Call for the first fiscal quarter that ended January 31, 2026. I'll begin with some high-level comments about the quarter and our strategy before Mayan dives deeper into the financials. Fiscal 2026 is off to a great start, and I'm excited for what still lies ahead. Revenue for the quarter was $178.3 million, up 25% year-over-year, growing at its fastest space in 10 quarters and up 9% sequentially. One quarter into the year, and we are at a revenue run rate exceeding $700 million. Also at $11.5 million, adjusted EBITDA was up 62% year over year, marking the fastest pace of growth in two years. Our domestic core bricks and mortar segment continues to outperform at peers with rising margins, which have now increased sequentially for five straight quarters and hitting 28%. At the same time, our newer international business is now picking up steam and reaching new highs since we acquired a majority interest in it. Let's recap how Germany is going. The Ramexian transaction closed on September 2nd, 2025. Revenue for the two months it contributed to Q4 results was just under $10 million, averaging $5 million a month. In Q1, Ramexian's revenue was $25 million, dollars, averaging over eight million dollars a month. In February alone, Ramexion sold 2.6 tons of medical cannabis and generated 12 million dollars of revenue, which was a record since we acquired a majority stake in the company. Additionally, preliminary gross margins improved to 20 percent in February. While we caution that any one month's performance may not be consistently repeatable, it nevertheless gives us a strong degree of confidence that looking ahead, Ramexion should be able to deliver results far ahead of the metrics used during the valuation period for the transaction. What gives me extra comfort is that February's strength was even before we start seeing the results of our strategy fully coming together. As mentioned on our last conference call, we have already begun sourcing tons of biomass from Canada at best-in-class terms, which are significantly better than what Ramexian was procuring on its own or through brokers. Given import permit delays, this biomass probably won't start reaching Germany for about a month. And after that is when we anticipate a sustained improvement in profitability at Ramexion. So I'm glad to say that it's all coming together. Of course, growing the Ramexion business, especially with meaningful inventory still stalled in Portugal and deposits for new biomass from Canada, which will go direct, requires working capital investments. Despite a modest drag in Q1 from Ramexian, I'm very proud to report that Hytai generated free cash flow on a consolidated basis. Q1 free cash flow was $2.9 million, marking a huge reversal from negative $1.9 million in Q1 last year and more than double the $1.3 million generated in Q4. We like to look at free cash flow generation over a longer term to get a better sense of To that point, despite constantly opening new stores, which act as a drag initially, including seven in Q1 alone, we have now generated $16.8 million of free cash flow on a trailing basis, which is the highest level in the past five quarters. The engine of this free cash flow has been a core Canadian bricks and mortar business, Canna Cabana, which backed by our innovative discount club model continues to expand. We are now at 2.58 million Canna Club members across Canada, up 47% year over year, marking the fastest growth rate in 10 quarters. Elite is growing even faster, up 100% year-over-year and reaching 162,000 members. These numbers give us confidence that we will reach our long-term goals of 3 million members in Canada, with over a million being elite. Our loyalty-based discount club is the largest in all of cannabis and truly the envy of the It features everyday discounts for members, as well as unique promotions such as our $100,000 420 giveaway, which was launched two weeks ago. Our store's financial performance continued to be very strong. Bricks and motor revenue was $150 million in Q1, a $600 million annual run rate. Backed by higher margin initiatives gaining steam, the segment generated its fifth straight quarter of sequential gains in gross margin, reaching 28% in Q1, which was the highest level in over three years. The segment's adjusted EBITDA margin maintained its high at 9% in the quarter. Our retail KPIs remain very impressive. Despite the extremely harsh weather, particularly in Ontario in January, we were able to still post positive same-store sales increases during the quarter on a year-over-year basis. Chaining our monthly same-store sales increases since launching our innovative discount club model in October of 2021, Canna Cabana was up 149% to December 2025. In contrast, the increase in total sales in the five provinces where we operate has mirrored the increase in the number of stores, implying that the average operator has had flat sales during this period. Our market share within the five provinces where we operate was 12% during November and December, which was up from 11% a year ago and 10% two years ago. Excluding stores open for less than six months, which are still ramping up, our annualized revenue per square foot in Q1 was $1,728, dollars, once again above many leading blue-chip retailers. In December, the average Cana Cabana store was on an annual revenue run rate of $2.5 million, which was 1.9 times a peer average at $1.3 million. In Ontario, the largest province and focus for future growth, our outperformance was even more pronounced. Excluding stores open less than six months, which are still ramping up, our average Ontario store was on a $2.9 million annual run rate, which was 2.6 times our peers at $1.1 million. For the 12 months ended December 2025, total industry sales in the five provinces where we operate were up 3% year over year. In contrast, total Canna Cabana sales were up 14% during this period. We've added 27 stores in the past 12 months, almost all organically. The key factors of our selection criteria is location and lease terms, as these are key pillars of sustained superior financial performance, and these decisions are set for years once they are made. We are happy with how our new stores are performing, but the ramp is naturally slower due to increased competition and a broader slowdown in industry growth rates. Despite the drag from new stores, it is very heartening to see the increases in gross profit and EBITDA in this segment. We are confident that these newer stores will gain traction and add to our financial profile in the quarters ahead. Regarding the outlook, we re-enerate our target to add 20 to 30 stores in Canada during this calendar year. Consistent with what we have achieved over the past two years, we expect this to be done mostly organically. We continue to look for supplemental M&A opportunities which can add shareholder value. we remain we maintain our target to exceed 350 stores across the country with new locations being additive to the total addressable market of consumers we can sign up to our loyalty programs as we scale up the contribution from our higher margin white label products will become more meaningful over the long term we plan to reach approximately 20 percent of our sales coming from our white label products versus 1.6 percent currently as always these will continue to be made only by quality licensed producers and largely represent differentiated products like our strong-performing Queen of Bud brand.
Turning to our U.S.
CBD e-commerce business, we are pleased to report that we are one of the founders of National Compassionate Care Council, an industry group aiming to shape U.S. federal cannabis policy following rescheduling efforts. It focuses on integrating cannabinoid therapies into mainstream medicine through research, education, and patient-focused advocacy. We believe this could be a meaningful opportunity for New Leaf and Fab CBD, especially given that the U.S. is poised to launch CBD pilot projects through Medicare. While we are bullish on this opportunity, we don't feel that the market has ascribed any value to it, and we know that Frederico Gomez at ATB Cormark published a report on the potential that this change could have on our business. While we are waiting for the regulations to be unveiled, there are already early signs that our e-commerce segment as a whole has stabilized and is even ticking higher. Generating its first sequential increase in two years in Q1 with gains in both the CBD and accessories businesses, the segment's drag on consolidated adjusted EBITDA was also the smallest in four quarters. So there are reasons for optimism both in terms of the current trajectory of our e-commerce businesses and the potential to turbocharge our CBD businesses in particular. That said, we have several options regarding future steps, including ongoing conversations to explore potential transactions. As always, we will look to what surfaces the most value for our shareholders. At the same time, we continue to evaluate opportunities to take our CannaCabana brand into the U.S. through licensing agreements. While we are in conversations with operators of different sizes, this will take time and we're being thoughtful regarding possible structure and partner. Coming back to Ramexion, we entered into this transaction for the long term. We are only just getting started on the synergies and while still present today, the issue of getting product out of Portugal will only alleviate from here going forward, which should boost margins versus what we reported in the past two quarters. Again, we note that a similarly sized German importer and distributor recently entered into an acquisition by a public company at a valuation significantly higher than our transaction with Ramexion. And a reminder that as the pricing for the put and call options with Ramexion's minority shareholders are set at 3.604 times, depending on the timing of the exercise, the future accretion for the remainder of the company is already locked in for high-tight shareholders. Ramexion continues to gain prominence within the German medical cannabis market. Despite the volume of biomass in Portugal still waiting to be released, Ramexion was able to significantly increase its market share of German imports from 6.5% for the three months ended September 2025 to 10.3% for the three months ended December 2025. As alluded to previously, total shipments since then have accelerated, with the average monthly shipments for January and February up 25% versus the three months ended December. And this is before we start to see the benefits of the tonnage procured in Canada, starting to arrive and enhance the segment's financial results. While there could be some headwinds in Germany, particularly regarding a new law governing the details surrounding medical cannabis access, we are encouraged by the ongoing debate in the German Parliament and are hopeful that the ultimate changes are likely to be more benign than what had been feared last year. Meanwhile, Ramexian continues to gain momentum. We are already a leader in Germany and as our strategy is starting to yield results there, we are looking to expand our ecosystem into other international markets. In particular, we are already meeting with key players in the UK with the aim of entering into a transaction in that country within the next 12 months. Another highlight of our quarterly results I would like to touch on was our strong cost controls. In particular, general and administration expenses represented just 4.1% of revenue, marking a six-quarter low. In conclusion, we are on the right track with many milestones achieved and many more ahead. We have now generated $42.6 million in adjusted EBITDA over the past 12 months, making us as profitable as we've ever been with expectations that all three of our segments will post gains in the quarters ahead. High Tide's future looks bright and it's worldwide. Thank you to our global team for making it all happen and for where we will go in the quarters ahead. On that front, I'm pleased to highlight that earlier this month, Kathleen Skerritt and Minashe Kestenbaum joined our board of directors. We also created two new advisory positions with David Wallisch and Philip Ernest to provide strategic guidance to management on matters including real estate, business development, artificial intelligence, e-commerce technology, and community and stakeholder engagement. Welcome to our Hightight family. I look forward to working with you all and achieving even greater heights ahead. With that, I'll turn it over to Mayank for his comments and a deeper dive into the numbers.
Thank you, Raj. And hello, everyone. Q1 was another great quarter for high tide. We expanded the network in Canada, so large improvements internationally realized record revenue all while generating increasing level of free cash flow. Let's take a deeper dive into the numbers. Revenue for Q1 was once again a new and all-time high at $178.3 million, up 25% year-over-year, the fastest pace of growth in 10 quarters, and up 9% sequentially. Consolidated gross margins were 25% in Q1, consistent with Q4 last year, and just below 26% sequentially. While our medical cannabis distribution generated a lower gross margin this quarter than its usual historical performance given supply chain delays in Portugal, as Raj mentioned, we anticipate improving gross margins in this segment looking ahead as fresh biomass from Canada purchased at best-in-class terms starts arriving in Germany. Most importantly, we were able to post sequential gains in our core brick and mortar segment for the fifth straight quarter to 28%, the highest level in over three years. Turning to expenses, salaries and wages represented 11.8% of revenue in Q1, marking a meaningful improvement versus 12.3% a year ago. and compared to 11.5% sequentially, which was a tough comparative as it marked our lowest level in nine quarters. General and administrative expenses represented 4.1% of revenue in Q1. This quarter was a continuation of this downward trend, comparing to 4.6% a year ago and 4.3% sequentially. It is great to see the demonstrated impact of operating leverage as we scale up our revenue. Adjusted EBITDA was $11.5 million for the quarter. This was an outstanding 62% year over year. The star of the show here once again was our core brick and mortar segment, which posted a 58% increase year over year. representing the fastest growth rate in seven quarters. The segment's adjusted EBITDA margins were 9% in Q1 which was consistent with Q4's high and materially above the 6% generated in Q1 last year. HITI generated $2.9 million of free cash flow in Q1 marking a very pleasant reversal from the $1.9 million investment in Q1 last year and more than double the $1.3 million generated in Q4. Over the past 12 months, we generated $16.8 million of free cash flow representing the highest level in five quarters. We continue to have a strong balance sheet. As of today, at the high-tide level, total debt stands at $64.5 million. We had $46.4 million in cash and restricted cash at the end of the quarter, and we are well positioned with no near-term maturities. In closing, Q1 was another great quarter for high-tide. We have a retail platform in Canada that is second to none with millions of loyal customers that are backbone of the company. In particular, our 162,000 elite members are growing 100% year over year and generate even higher sales than base members. Our newly consolidated international business is showing great momentum which has carried into our second fiscal quarter with February sales at $12 million. And as Raj mentioned, this is even before we start seeing the tangible impacts of our procurement expertise. This gives us the confidence to now look at other jurisdictions where we can take our ecosystem and carve out yet another leadership position. Thanks to our amazing team, without whom none of this would be possible. With that, I will now turn the call over to the operator to open the line for the question and answer session.
Thank you. Ladies and gentlemen, we will now begin the question and answer session. Should you have a question, please press star, followed by the one on your telephone keypad. And should you wish to cancel your request, please press star, followed by the two. If you are using a speakerphone, please lift the handset before pressing any keys. One moment, please, for your first question.
Thank you.
And your first question comes from the line of Luke Hanan from Canaco Genuity. Please go ahead.
Thanks. Good morning, everyone. First, I wanted to start with the same-store sales performance that you had in Canada during the quarter. You mentioned you did still deliver growth year on year despite the impact of the winter storms. But can you just delineate for us what exactly was the impact of the winter storms, either on a same-store sales basis or whatever other basis you're comfortable sharing? And then also just give us an indication of where that metric is trending quarter to date.
Good morning, Luke. Thank you for your question. So, yes, same-store sales were definitely impacted mostly in the last 10 days of January. sorry to last 10 days of January and it also extended a little bit into February but that was a once-in-a-lifetime event in Ontario you know things were closed I believe you're from Ontario so you would know Luke how serious that was but barring that you know the reality is that things are definitely slowing down a little bit in Canada and you know when the market is doing that all you can do is outperform the market as an illustration Luke let's look at the three months ended December 2025, the last month we had Statistics Canada data available. And let's exclude BC, given I'm sure you remember the strike impact there. It was a once-in-a-lifetime kind of event there as well. So total industry sales, including the impact of opening new stores, were down across those four provinces for the three months ended December. This was the first time since legalization that total sales over a three-month period were negative year-over-year. And it wasn't just due to marginal players. We actually saw a public company report negative same store sales year over year during those three months as well. So like I said, you know, we can only outperform the industry. In contrast, our same store sales were up 2% during those months. And then again, you know, our same store sales in January were up as well, but only by a little. So the macro consumer outlook is obviously a big driver and all we can do is, you know, continue to outperform. And given the strength of our model, our tier one real estate selection, our team superior execution, we believe that we will continue to outperform the market. Like I said, we posted positive same-store sales increases in January as well. But the silver lining here, Luke, is as the growth slows, in addition to outperforming the market in general, this is going to put even more pressure on those marginal players that we've been talking about, which are going to be becoming even more incentivized to exit the market. And when they close, those sales have to go somewhere and we believe they will disproportionately go to us.
And then for my follow-up here, and then I'll pass the line, you talked about wanting to get into the UK market in the next 12 months. Can you just give us an idea of what exactly you're looking for, maybe how you intend to fund a deal there? You expect to structure it similar to Rumexian. And then on that note as well, what What are you seeing as far as the multiples and the kind of assets that are available?
Yeah, sure, Luke. So, Luke, given that we're already a leader in Germany and our strategy is starting to yield results there, we're looking to expand our ecosystem, obviously, into other international markets. This is something that I've been talking about, that Germany is just a start. It's a step into other European markets as well. And, you know, UK is a very exciting market, Luke. It's been growing at 100% year over year. That's what it did last year. that's what it's projected to do this year between 60 to 100 percent so that's very very exciting for us so what we're doing right now is we are meeting all key players in the uk i've probably spoken to five groups already and another five or seven are on my list to speak with this is ongoing we are in no rush to enter that market so it's not like we're cash trapped and we need to do something tomorrow in the uk market but we are very well we're definitely prospecting the key players there because it's going to become a very important market for high tide. It's definitely one of those markets where Canadian cannabis is making huge waves. It's close to that same 50% benchmark that we've been talking about in Germany. So down the road, we have an aim of entering into a transaction in that country within the next 12 months.
Very helpful. Thanks so much.
Thank you.
And your next question comes from the line of Neil Gilmer from Haywood Securities. please go ahead.
Yes, thanks very much and good morning. Yeah, I'm in Ontario too. It's been a brutal winter, but I won't get into that. I wanted to talk about Germany. You commented on the February sales of 12 million and a gross margin of 20%. It's a two-part question here. Number one, you know, if I take the 12 and times it by three, obviously I get 36, which seems like, you know, significant growth over 25. I don't want to get, you know, over my skis or sort of what sort of message you want to sort of send to investors? Was there anything unique about February or should we be sort of thinking of that sort of run rate going forward? And number two, the 20% gross margin that you disclosed, are you comfortable providing a range of where you think the gross margin could be once you get these Canadian sales into the German market?
Good morning, Neil. Thank you so much for your question. So, you know, I'm definitely excited about what's happening at Ramexian. So like I said in my prepared remarks, Neil, Q4 average revenue per month was $5 million through Ramexian sales. Q1 average revenue was $8 million. And February revenue alone was $12 million, the highest since we acquired a majority stake. So look, we're very encouraged with how the overall business is trending. But that said, we continue to have meaningful biomass waiting to be released in Portugal, right? We still have seven, eight tons in Portugal that are coming through. We started with 17 and we're down to about seven or eight. And as mentioned, you know, February was the best month by tonnage since we acquired Ramexian in September. Now, some of this was, you know, more biomass being released from Portugal, but it was also supplemented by opportunistic buying by the Ramexian team in countries outside of Portugal. So, you know, the Portugal issue will still weigh in on Ramexian results for Q2. And no one month should be taken as, you know, the benchmark going forward. Right. Again, I have March's numbers. They're slightly softer than February, but that's, again, because of import permit delays and things like that, although I am very bullish about Ramexian's performance going forward. The second part of your question, I believe, was on the gross margins. We definitely were excited to see that we are already at 20% gross margins in February. Like I said, it's probably not repeatable every month, at least for the next couple of months, but I am very, very confident that it could become the norm going forward in Q3 and beyond. But we're looking at a range of 20 to 25%. I don't even think it stops at 20. I think we hit mid 20s gross margins, probably capped at around 25%. Because like I said, you know, the Canadian biomass that we procured at best in class prices and best in class terms have not even landed in Germany, it was supposed to be in Germany in the second week of March. That's not happened because of the import permit delays into Germany. So now that's trending towards March, but we've already hit 20% without this biomass. So when that comes in, it gives me good heart that we could see between 20% to 25% gross margins going forward.
Okay, thank you. I guess maybe the second follow-up question, and then I'll pass the line, is back in Canada here. I take it from your prepared remarks, you talked about the 20% to 30% that you plan to open this year, mostly being organic. It just sounds like it's a pretty dry M&A landscape. So is my correct assumption that that organic growth that you plan to do is mostly going to be focused on the Ontario market? Or can you talk about whether there's any other markets where you think that will drive that increase in retail stores?
Yeah, absolutely, Neil. So look, the organic store goal 20 to 30 is a tried and tested benchmark for us, which we've been doing for the last couple of years. Now, it's definitely getting harder, Neil, to get good organic locations where we don't run into redundancy with our own portfolio or where it's not already an ultra crowded market, but same-store sales pressures on everybody. So that's a balancing act. Maybe we're towards the lower end of the organic growth trajectory this year, but we definitely feel that we would still be able to hit that milestone. To your question about whether that growth is focused on Ontario, it absolutely is focused on Ontario because we can probably still add 54 stores to get to our 150. So there's a lot of growth ahead of us in Ontario. But we continue to grow in other markets as well. In our home province of Alberta, we're in the 90s here, mid-90s here for store count. I believe we can get to close to 130 stores in Alberta as well. Saskatchewan is open playing territory as well where we have 13 stores, but we believe we can get to 20 plus stores in Saskatchewan. So the growth will not be limited to Ontario alone, although the focus is definitely on the Ontario market.
Great, Raj. Appreciate that. Thanks. I'll pass the line.
Thank you. And your next question comes from the line of Federico Gomez from ETB Cormark. Please go ahead.
Good morning. Thanks for taking my questions. The first question on your bricks and mortar gross margins, you've been doing pretty well there, fifth consecutive quarter of expansion. But given the market slowdown on the sales side that we're seeing that you mentioned, as the market matures, are you expecting to continue to report new sequential margin expansion in that segment? Or could that sales slowdown impact that? Thank you.
Good morning, Fred. Thank you for your question. So look, I'm very happy to see that we've had 28% and gross margins in a brick and mortar segment, which is five consecutive quarterly increases that we've seen at that segment. And I couldn't be more happier, but you're right. Can we continue this forever? Probably not. Probably not. But the one thing we've said from the very beginning is that our white label initiatives and elite sales, which continue to pick up steam, as you know, white label has now jumped from 1.3% to 1.6% with a long-term goal of getting to 20%. 100%. That'll happen over the next five years, but that will boost gross margins. Each white label SKU contributes to another 6% to 7% additional gross margins on our side, but we're very thoughtful about it. We want to introduce differentiated cannabis products that are made by quality licensed producers, so we're going to take it slow and steady. And then the other major initiative that's contributing towards gross margins that will continue to do so is our elite sales. As you know, elite is growing at 100% year over year, faster than our own expectations here. If it does that another year, we'll be close to 350,000, 320,000 elite members. This is very, very exciting, but that also means that, you know, it helps with our gross margins because it's consolidated. It adds another, you know, it's a 70% gross margin segment for us, which is very, very healthy. But at the same level to offset that, you know, we still have illicit market pressures. The competitive pressure is still quite strong. And sometimes we have to adjust our margin downwards in many of our locations to remain competitive and then gain steam again when other operators cannot hold and cannot compete with us, right? So overall, think of, you know, if I can do another quarter or two of 28%, I'm very happy. I don't think it trends downwards, maybe slightly, but I don't think so. But we've got elite and white label sales to back it up, to keep going, to keep chugging it ahead slightly, at least in the coming quarters.
Thank you, Raj. Appreciate that. And then a second question, just on your e-commerce platforms, you mentioned early signs of recovery and obviously revenue increased sequentially for the first time in two years. So what changes have you implemented recently in that business to drive that recovery? And since the quarter ended, has the trend continued with continued improvement?
Sounds good, Fred. So on the e-commerce front, we have implemented quite a few changes. As you know, we appointed Sri as our VP of technology about five months ago now, and she's been doing a stellar job since she's come on board. We had identified that, you know, given our three-tier pricing strategy, we had some issues with our tech stack, which we've now changed in five of our platforms. We've relaunched Smoke Cartel, Dangstop, Daily High Club. Grass City was just relaunched about a week ago, and New Leaf Naturals has also been relaunched, and we're seeing very encouraging signs. We're seeing conversion up 30% to 50%. We're seeing orders up 30%. We're up 5% quarter over quarter in both our business segments, which is accessories and CBD businesses showing increases. And this is prior to the potential favorable regulatory changes for the CBD industry that I was talking about initially in my prepared remarks. So, you know, this is all resulting on the segment's consolidated drag on EBITDA also coming down, which has been the smallest in four quarters. And you're absolutely right. We're already seeing that momentum carrying forward into Q2 as well.
Thank you very much. I'll be back in the queue.
Thank you. And your next question comes on the line of Bill Kirk from Roth Capital Partners. Please go ahead.
Good morning, everybody. My first question, Canada is set to lower medical reimbursement amounts. would you expect the recreational market and your stores to benefit from that change to the medical program?
Good morning, Bill. Thank you for your question. So, you know, the medical industry, cannabis industry in Canada has been shrinking. The patient numbers have considerably gone down. And I don't think that the medical cannabis clientele is competing with the recreational cannabis industry. So I don't think that it's going to matter much. There are cannabis stores on practically every city block or every two, three city blocks in the country. So the convenience factor is already there when it comes to recreational cannabis sales, and we're extremely competitive at the recreational level now, even with the illicit market. Although illicit market continues to make mayhem on the edible side of things, but we're very competitive. But this change on the medical side is not going to have an impact on the recreational side. I think so.
Okay, thank you, Raj. And then going back to Germany, there was a comment in the press release about more than one out of seven German pharmacies are now offering cannabis. Do you have an expectation for how widely available product can become in that market as it matures?
Sure, Bill. So, look, it's already exceeding our expectations in terms of how the German market is growing. It's at 227 tons annualized. You know, B-Farm released their Q4 data and they revised Q3 upwards. So they did 57 tons in Q4, which was actually the same level of imports that B-Farm had previously published for Q3. And the Q4 number is up 75% year over year, right? So that's huge growth right there. And from a big picture perspective, you know, the market has gone from 33 tons when it started in 2024 to 227 tons right now. So there's a lot of growth that's already happened. We're only 10% of the market right now. We think we're going to continue to increase. It's nice to see more and more pharmacies starting to offer medical cannabis products. The patient growth has also gone up from 200,000 patients to now exceeding 1 million patients in Germany. So we're very happy with where things are at. And even if growth was to slow down a little bit, I think this is a massive market already.
Thank you. I'll pass it along.
Thank you. Once again, that is Star and want to ask a question. And your next question comes from the line of Derek Lazard from TDKWN. Please go ahead.
Good afternoon, everybody, and congrats on a great quarter. I just wanted to know, given your insights with your POS and your loyalty program, do you have any, I guess, at least first thoughts as to why the market may have slowed or consumption?
Good morning, Derek. Thank you for your question. So the market slowing a little bit could be a result of the dollars that are available in consumers' pockets. We know that there's inflationary pressures here in Canada. We know a potential recession could be looming with what's happening worldwide and just the angst in consumers' minds. And also, we do go through these phases where illicit picks up a little bit and takes a little bit of a bite of the legal market, and that we continue to see in different pockets of the country. So that is probably also making a difference. But given that we are at the forefront of the industry and have been a leader for a very long time, I think Canna Cabana will be a disproportionate recipient when these sales come back and when this momentum comes back in the Canadian market. So I am not concerned about it.
Okay, I'd agree with that. And I guess, you know, one of your competitors did point to higher selling prices and more of a promotional period a year ago. So I was just curious, too, I guess, around the, you know, the potential impact of a slowdown. Do you think you see any room or concern for any type of irrational competitive behavior from some of your competitors or the ones who are, you know, just kind of still trying to stay in business?
Yeah, it's definitely possible, right, Derek? This is business. Business never goes up in a straight line. No competitor is the same. and there's different competitors coming and going. So we definitely feel competitive pressures and this quarter in particular, you know, Q2 is the slowest quarter of the year in which we are in. And Q1 that we just finished, as you mentioned, the industry growth sales slowed overall. And some competitors, you know, try to change their strategy just to see if they can come out of it and still survive. That's not happened to date. We're going to stick to our strategy. We're not raising prices on consumers. We have been gently raising prices, as you can see over the last five consecutive quarters, we've had gross margin increases at the brick and mortar level. But we're not going gung-ho on this and raising prices on consumers. We want to make sure it's steady and stable and we're able to enjoy margin increases through our white-label program and through elite versus raising store-level margin increases.
Appreciate your answers, Raj, and congrats on the quarter again. Thanks.
Thank you. And your next question comes from the line of Tom Kerr from Zax.
Please Good morning, guys. Most of my questions have already been answered and asked. Just I want to follow up on new store growth in Canada. And you might have mentioned this, but with the industry slowdown, does it still make sense to do the 2030 stores or would you wait for a turnaround in the entire industry? Just how do we look at that?
Good morning, Tom. Thank you for your question. So look, we give a range of 20 to 30 stores. Like I mentioned in my prepared remarks, it is getting a little difficult to find organic locations where it's not redundant to our portfolio, our existing stores already. And it's also getting difficult in the sense to find organic locations where you have a superior power center, which is not surrounded by a lot of competition. So, we're being very careful in terms of where we plot these stores. Now, we may be at the lower end of that target and do about 20 stores this year, but that would still be a very healthy organic same-store sales increase. We are more focused on M&A this year, so we should be able to get some M&A done this year at the brick-and-mortar level, which will not be a net increase into the market where we'd be taking over existing stores. okay got it uh one more quick one and just on the transition or the push to get uh members to the elite subscription status is that marketing is it sales is it advertising is it more benefits you know how are you going to push that look it's a little bit of everything right we're we're focused on our marketing our sales the advertising around it but but our consumers our customers our club members are genuinely seeing the value in Elite, right? Like I said, when times are tough, as you can see right now, people are not rushing to the till to become an Elite member, or they shouldn't be rushing to a till to become an Elite member to spend $35 a year, but they're doing that because they see the value in everyday discounts. They see that exclusive product selection is very, very good, and they're excited about it. So, Elite gets a lot of benefits, and I'm very happy to see that they're seeing value in these tough times or these slow times. And I don't think that elite momentum is slowing down anytime soon. We were growing at 100% year-over-year last year. We're still growing at 100% year-over-year right now. And if this keeps happening, we'll be at 320,000 members in no time.
Great. Thanks for the detail on that. That's all I have for today. Thanks.
Thank you. There are no further questions at this time. I will now hand the call back to Raj Grover for any closing remarks.
Thank you, Operator, and thank you to everyone for your interest and continued support for HITI. We're very proud of what we achieved this quarter and remain excited about the road ahead. With that, I'll ask the Operator to close the line. Have a great day, everyone.
This concludes today's call. Thank you for participating. You may all disconnect.
20:57 to 43:11 · One card per analyst, follow-ups included. Each plays from its start, and the one being answered is marked.
Thanks. Good morning, everyone. First, I wanted to start with the same-store sales performance that you had in Canada during the quarter. You mentioned you did still deliver growth year on year despite the impact of the winter storms. But can you just delineate for us what exactly was the impact of the winter storms…
Raj Grover: Good morning, Luke. Thank you for your question. So, yes, same-store sales were definitely impacted mostly in the last 10 days of January. sorry to last 10 days of January and it also extended a little bit into February but that was a once-in-a-lifetime event…
Very helpful. Thanks so much.
Speaker 3: Thank you.
Yes, thanks very much and good morning. Yeah, I'm in Ontario too. It's been a brutal winter, but I won't get into that. I wanted to talk about Germany. You commented on the February sales of 12 million and a gross margin of 20%. It's a two-part question here. Number one, you know, if I take the 12 and times it by…
Raj Grover: Good morning, Neil. Thank you so much for your question. So, you know, I'm definitely excited about what's happening at Ramexian. So like I said in my prepared remarks, Neil, Q4 average revenue per month was $5 million through Ramexian sales. Q1 average…
Good morning. Thanks for taking my questions. The first question on your bricks and mortar gross margins, you've been doing pretty well there, fifth consecutive quarter of expansion. But given the market slowdown on the sales side that we're seeing that you mentioned, as the market matures, are you expecting to…
Raj Grover: Good morning, Fred. Thank you for your question. So look, I'm very happy to see that we've had 28% and gross margins in a brick and mortar segment, which is five consecutive quarterly increases that we've seen at that segment. And I couldn't be more happier…
Thank you very much. I'll be back in the queue.
Good morning, everybody. My first question, Canada is set to lower medical reimbursement amounts. would you expect the recreational market and your stores to benefit from that change to the medical program?
Raj Grover: Good morning, Bill. Thank you for your question. So, you know, the medical industry, cannabis industry in Canada has been shrinking. The patient numbers have considerably gone down. And I don't think that the medical cannabis clientele is competing with the…
Also speaking: Speaker 3
Good afternoon, everybody, and congrats on a great quarter. I just wanted to know, given your insights with your POS and your loyalty program, do you have any, I guess, at least first thoughts as to why the market may have slowed or consumption?
Raj Grover: Good morning, Derek. Thank you for your question. So the market slowing a little bit could be a result of the dollars that are available in consumers' pockets. We know that there's inflationary pressures here in Canada. We know a potential recession could be…
Appreciate your answers, Raj, and congrats on the quarter again. Thanks.
Raj Grover: Good morning, Tom. Thank you for your question. So look, we give a range of 20 to 30 stores. Like I mentioned in my prepared remarks, it is getting a little difficult to find organic locations where it's not redundant to our portfolio, our existing stores…
SEC call announcement
Filed Mar 17, 2026 · complete as-filed document